ATE78689T1 - Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums. - Google Patents

Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums.

Info

Publication number
ATE78689T1
ATE78689T1 AT88108022T AT88108022T ATE78689T1 AT E78689 T1 ATE78689 T1 AT E78689T1 AT 88108022 T AT88108022 T AT 88108022T AT 88108022 T AT88108022 T AT 88108022T AT E78689 T1 ATE78689 T1 AT E78689T1
Authority
AT
Austria
Prior art keywords
thiaprostaglandin
antidiabetic
chain
derivatives
manufacture
Prior art date
Application number
AT88108022T
Other languages
English (en)
Inventor
Toshio Tanaka
Yukio Motoyama
Original Assignee
Teijin Ltd
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd, Fujisawa Pharmaceutical Co filed Critical Teijin Ltd
Application granted granted Critical
Publication of ATE78689T1 publication Critical patent/ATE78689T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88108022T 1987-05-28 1988-05-19 Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums. ATE78689T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12998487 1987-05-28
EP88108022A EP0292870B1 (de) 1987-05-28 1988-05-19 Verwendung von -7-Thiaprostaglandin E1 oder seinen Derivaten zur Herstellung eines Antidiabetikums

Publications (1)

Publication Number Publication Date
ATE78689T1 true ATE78689T1 (de) 1992-08-15

Family

ID=15023281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88108022T ATE78689T1 (de) 1987-05-28 1988-05-19 Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums.

Country Status (8)

Country Link
US (1) US4937265A (de)
EP (1) EP0292870B1 (de)
JP (1) JP2503047B2 (de)
KR (1) KR880013562A (de)
AT (1) ATE78689T1 (de)
AU (1) AU604547B2 (de)
CA (1) CA1311417C (de)
DE (1) DE3873170T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2164865A1 (en) * 1993-06-18 1995-01-05 Jiro Seki Suppressant for vascular hypertrophy and suppressant for wandering smooth muscle cells containing 7-thiaprostaglandin e1 compound as active ingredient
AU6017396A (en) 1995-06-26 1997-01-30 Teijin Limited Prostaglandins and process for producing the same
GB9715444D0 (en) * 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
US6410591B1 (en) * 2001-05-08 2002-06-25 Allergan Sales, Inc. 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
US20030027853A1 (en) 2001-06-14 2003-02-06 Allergan Sales, Inc. 3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
US7872045B2 (en) 2001-06-14 2011-01-18 Allergan, Inc. Combination therapy for glaucoma treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2422924A1 (de) * 1974-05-11 1975-11-27 Merck Patent Gmbh Thiaprostaglandine
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
JPS60185761A (ja) * 1984-03-05 1985-09-21 Teijin Ltd 7−チアプロスタグランジンe↓1類およびその製造法
JPS6130569A (ja) * 1984-07-20 1986-02-12 Teijin Ltd 7−チアプロスタグランジンe↓1エステル類の製造法

Also Published As

Publication number Publication date
CA1311417C (en) 1992-12-15
DE3873170D1 (de) 1992-09-03
AU1669288A (en) 1988-12-01
EP0292870A2 (de) 1988-11-30
EP0292870A3 (en) 1989-10-18
US4937265A (en) 1990-06-26
EP0292870B1 (de) 1992-07-29
DE3873170T2 (de) 1992-12-03
JP2503047B2 (ja) 1996-06-05
JPS6452721A (en) 1989-02-28
KR880013562A (ko) 1988-12-21
AU604547B2 (en) 1990-12-20

Similar Documents

Publication Publication Date Title
ES2061845T3 (es) Un procedimiento para preparar un compuesto espiro.
ES425084A2 (es) Procedimiento para la preparacion de aminoalcoholes.
DE3370585D1 (en) Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation
DE69305276D1 (de) Arylglycinamidderivate, Verfahren zur deren Herstellung und deren Verwendung zur Therapie der Dysurie
ATE86860T1 (de) Praeparat gegen ulcus.
NZ219576A (en) Milbemycin derivatives and pharmaceutical, veterinary, and pesticidal compositions
ATE78689T1 (de) Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums.
GB2020279A (en) Piperazinylbenzoheterocyclic compounds
ES481551A1 (es) Procedimiento de preparacion de nuevos compuestos bis (ari- loxicarboxilicos).
GB1510977A (en) Tetrahydropyridine and piperidine derivatives and processes for the production thereof
ES495106A0 (es) Un metodo de preparar derivados de fenil-piperazina farma- ceuticamente activos
EP0103320A3 (en) Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
HUT50464A (en) Process for producing phenothiazin derivatives
EP0069049A3 (en) Delta-8,9-prostaglandin derivatives, process for their preparation and their use as medicaments
ES8104247A1 (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden- hidracionopiridacina
ES468133A1 (es) Procedimiento para preparar derivados del cornezuelo del centeno
ATE112682T1 (de) Isocarbacyclinderivate enthaltende antidiabetika.
DE3163803D1 (en) 2-methyl-5-thiazole-methylamine and carboxamide derivatives
HUT48253A (en) Herbicide compositions containing new macrolid compounds and process for producing new macrolid compounds and pharmaceutical compositions containing them as active components
DE68909143D1 (de) Prostaglandin-Vorläufer und ihre Herstellung.
ZA906446B (en) Therapeutic agents for the treatment of peptic ulcer disease
ES488388A1 (es) Procedimiento de preparacion de derivados hidroxilados del tiazol
ES467237A1 (es) Procedimiento para la preparacion de derivados de ciclopro- pano.
DE68921673D1 (de) 3-Deoxymycaminosyltylonolidderivate.
ATE86629T1 (de) 4-piperidincarboxamid-derivate.